Kinnate lays off 70% of employees, shaves pipeline to focus on CDK4 and pan-RAF inhibitor
Kinnate Biopharma has reduced its employee headcount by 70% — leaving just 28 full-time employees — and is “separating” from all employees at its Chinese subsidiary, Kinnjiu …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
